Movantik
Chemical Name | naloxegol |
Dosage Form | Tablet (oral; 12.5 mg, 25 mg) |
Drug Class | Opioid antagonists |
System | Digestive |
Company | RedHill Biopharma |
Approval Year | 2014 |
Indication
- For the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent (e.g., weekly) opioid dosage escalation.